Significantly higher (P<0-05) thrombin-antithrombin III complex levels were found in the abdominal exudate of patients with peritonitis (median 5500 ng/ml) than in that of controls (median 89 ng/ml). In patients, peritoneal fluid concentrations of tissue and urokinase-type plasminogen activator were increased by factors of 65 and 10 respectively (P<0-05). The concentration of plasminogen activator inhibitor (PAI) 1 was increased by a factor of about 800 (median 395 versus 0-5 ng/ml, P<0-05). Despite markedly raised concentrations of PAI, peritoneal fluid displayed fibrinolytic activity as demonstrated by significantly increased ( P < 0 '05) concentrations of plasmin-a2-antiplasmin complex (median 10 952 versus 57 ng/ml) and fibrin degradation products (median 40 360 versus 126 ng/ml). There was no correlation between plasma and peritoneal fluid concentrations. Intra abdominal coagulation and fibrinolysis are stimulated in the abdominal cavity of patients with bacterial peritonitis.
« ■ m m * In bacterial peritonitis, fibrin is formed in the peritoneal cavity as a r of activation of the intra-abdominal coagulation cascade. Intraperitoneal fibrin plays a key role in the local host response to bacterial invasion, and prevents early bacteraemia and sepsis by entrapment of bacteria1. The role of fibrin is only temporary and fibrin must be degraded for normal tissue function to resume. When intra-abdominal fibrin persists, it acts as a nidus for infection, resulting in an intra-abdominal abscess2. In patients with bacterial peritonitis, intra-abdominal abscesses are associated with marked morbidity and mortality3,4.
For the degradation of intra-abdominal fibrin, stimu lation of the intraperitoneal fibrinolytic system is required. However, fibrinolytic activity is reduced during bacterial peritonitis, experimental demonstrated in several 5 -7 Diminished plasminogen activator (tPA) and increased plasminogen activator inhibitor (PAI) from peritoneal tissue have been considered to be important reasons for the reduced fibrinolysis7. Recently, the authors have demonstrated an increase in both tPA and PAI activity in the abdominal exudate of rats with faecal peritonitis, but this not correlate with the extent of damage6. In patients with peritonitis, research has thus far confined to peritoneum 8. T he aim of the present study was to assess coagulation and fibrinolytic activity in the abdominal exudate and plasm a o f patients with bacterial peritonitis.
Patients and m ethods 'Sl<>
Ethical approval was obtained from the hospital ethics com mittee. Twenty-five patients who laparotomy for peritonitis were studied. Peritonitis was due to perforated appendicitis in ten patients, duodenal perforation in five, perforated diverticulitis in five, small bowel perforation in two, toxic megacolon with perforation in two, ascites due to pancreatic necrosis in one. Abdominal cultures revealed bacterial growth in all patients. There were 16 male and nine female patients of mean age 48 (range 11 -90) years.
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Seven patients undergoing elective cholecystectomy for gall stone disease served as controls (three men and four women, mean age 50 (range 12-75) years). Bacterial cultures of the peritoneal fluid were negative in all control patients. After incision and meticulous haemostasis, 10 ml of peritoneal fluid were aspirated from the abdominal cavity of all patients with peritonitis. In patients undergoing cholecystectomy, the amount of fluid aspirated varied between 0-5 and 2 ml, and was diluted with normal saline to a total amount of 10 ml.
Venous blood (10 ml) was drawn simultaneously with peritoneal fluid aspiration. Peritoneal fluid and collected in a citrate tube (1:10) and a Stabilyte (Biopool, Umea, Sweden) tube (1:10) respectively, and placed in melting ice'1. Within 30 min the samples were centrifuged at 4°C and supernatants stored at -80°C until assays were performed.
Activation of coagulation was thrombin-antithrombin III (TAT) complex, by measuring the n generation is the final step in the coagulation cascade before tPA, urokinase-type activator (uPA), PAI-1, plasmin-«2-antiplasmin (PAP) complex and fibrin degradation products were measured.
Assays
The concentration of TAT complex was measured by enzymelinked immunosorbent assav (ELISA) >ent assay Behringwerke, Marburg, Germany). of tPA a was measured by ELISA tPA; Boehringer, Mannheim, many). assay measures both free and complexed (with PA M ) human tPA and is calibrated against the international standard for tPA.
by 
Results

Activation of coagulation in the abdominal exudate of patients with peritonitis was demonstrated by significantly
TAT complex concentrations, compared with controls (Table 1) . Stimulation of the fibrinolytic system in the peritoneal fluid of patients with peritonitis was demonstrated by significantly raised levels of tPA, uPA, PAP complex and fibrin degradation products, compared with those found in the peritoneal fluid of controls (Table  1) . Median peritoneal fluid concentrations of tPA and uPA in patients with peritonitis were about 65-and tenfold respectively higher than values in controls. PAI-1 antigen showed an 800-fold increase. Hence, concen trations of PAP complex and fibrin degradation products in the peritoneal fluid of patients with peritonitis were significantly raised in comparison with those in controls.
By contrast, plasma concentrations of TAT and PAP complex, and tPA and PAI-1 antigen and activity, were comparable in patients with and without peritonitis. Only degradation products in patients with peritonitis were higher than those in control patients (Table 2) .
Neither in those with peritonitis nor in control patients did the level of any coagulation or fibrinolytic factor measured in the plasma correlate with that observed in the peritoneal fluid.
D iscussion
This study demonstrates that, in the abdominal cavity of patients with bacterial peritonitis, both the coagulation cascade and the fibrinolytic system are stimulated. The resultant deposition of fibrin probably reflects a relative deficit of fibrinolytic activity, resulting from strongly enhanced inhibition of plasminogen activators.
The markedly raised concentration of TAT complex in the peritoneal fluid of all patients with peritonitis demonstrates intraperitoneal stimulation of coagulation. The coagulation cascade may be triggered by expression of tissue factor (procoagulant activity) on injured méso thélial and endothelial cells in the peritoneum13-15 and on peritoneal macrophages, which express tissue factor following stimulation with, for example, endotoxin and tumour necrosis factor (TNF)15,16. The relative contribution of separate cell types to intra-abdominal coagulation has not yet been clarified. It seems that activation of coagulation was confined to the abdominal cavity, as the plasma TAT complex concentration in most patients with peritonitis was not raised. In a few patients with sepsis, high plasma levels of TAT complex were found, which is in concordance with earlier reports on the sepsis and systemic hyperplasma concentrations uPA antigen and fibrin relationship between coagulability17'18. These data show increased levels of fibrinolytic activators following peritonitis. This finding is in agreement with that of Dorr et al,ll), who reported increased fibrinolytic activity and fibrin degradation in the peritoneal fluid of women with pelvic inflammatory disease. Increased tPA antigen levels in the peritoneal fluid, associated with normal plasma levels of tPA antigen in patients with bacterial peritonitis, suggest local production of tPA. In particular, mesothelial cells and submesothelial endothelium might be responsible for the production of tPA20,21. The increased tPA concentrations found in the present study might be explained by prompt release from a preformed storage pool within these cells. Several 'stress factors' and inflammatory mediators, stimulated by bacterial infection, may induce such a release of tPA in vivo22. However, these findings are not supported by in vitro experiments in which inflammatory 
